Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16691682 | 0.98 | GAA (0.50) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL6260925 | 0.98 | GAA (0.50) | GAAMGAMSIMGAM2CYP1A2 | |
| Ethylene SCHEMBL10805736 | 0.95 | CYP1A2 (0.48) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL185784 | 0.90 | GAA (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL22780 | 0.87 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| Succinic Acid Diethyl Ester SCHEMBL27768067 | 0.87 | GAA (0.67) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL4807580 | 0.86 | CYP1A2 (0.59) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL3947515 | 0.86 | CYP1A2 (0.59) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL11053326 | 0.84 | ALDH1A1 (0.57) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL6253597 | 0.84 | CYP1A2 (0.57) | GAAMGAMSIMGAM2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989690-A | Preparation method of self-hydrophobic heat-insulation board surface layer | 浙江工业大学 | 2022-09-02 | — | — | CN | claimed |
| US-20210123867-A1 | METHOD FOR THE DETERMINATION OF FILM FORMING AMINES | KURITA WATER INDUSTRIES LTD. (JP) | 2021-04-29 | — | — | US | claimed |
| CN-107876092-A | The high stability titanium catalyst of ester exchange carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2018-04-06 | — | — | CN | claimed |
| CN-107417719-A | A kind of titanium chelate catalyst for being used for carbonate synthesis benzene methyl and diphenyl carbonate | 华东理工大学 | 2017-12-01 | — | — | CN | claimed |
| US-20160271896-A1 | METHOD OF MANUFACTURING SOLE WITH SHOE NAIL MADE OF DIFFERENT MATERIAL | YANG TENG-JEN (TW) | 2016-09-22 | — | — | US | claimed |
| US-20160114546-A1 | METHOD OF MANUFACTURING SOLE WITH SHOE NAIL MADE OF DIFFERENT MATERIAL | YANG TENG-JEN (TW) | 2016-04-28 | — | — | US | claimed |
| CN-105522738-A | Method for manufacturing sole with shoe nails made of different materials | YANG DENGREN | 2016-04-27 | — | — | CN | claimed |
| CN-1193980-C | Method for synthesizing stereoselectively and efficiently diphenyl butane lignan compound | NO 1 HOSPITAL ATTACHED TO NO 3 (CN) | 2005-03-23 | — | — | CN | claimed |
| CN-1405142-A | Method for synthesizing stereoselectively and efficiently diphenyl butane lignan compound | NO 1 HOSPITAL ATTACHED TO NO 3 (CN) | 2003-03-26 | — | — | CN | claimed |
| US-4470881-A | USING A HIGHER BOILING SOLVENT WHICH AFFECTS VOLATILITY DIFFERENTIAL AND DOES NOT FORM AN AZEOTROPE | CELANESE CORPORATION (US) | 1984-09-11 | — | — | US | claimed |
| EP-4041795-B1 | BLOCKED ISOCYANATE POLYURETHANE COMPOSITIONS USING A NEW BLOCKING AGENT, METHOD OF MANUFACTURE AND USES THEREOF | CROMOGENIA UNITS (ES) | 2025-10-01 | — | — | EP | disclosed |
| US-12281101-B2 | Bicyclic lactams and methods of use thereof | GENENTECH, INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | BIOSYNTHIS (FR) | 2024-05-02 | — | — | US | disclosed |
| EP-3760625-B1 | BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES | HOFFMANN LA ROCHE (CH) | 2024-03-27 | — | — | EP | disclosed |
| WO-2024024438-A1 | CLATHRATE COMPOUND AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | disclosed |
| US-4555578-A | Mercaptotetrazolylalkanohydroxamic acids, salts and ester thereof | SHIONOGI & CO., LTD. (JP) | 1985-11-26 | — | — | US | disclosed |
| US-4470881-A | USING A HIGHER BOILING SOLVENT WHICH AFFECTS VOLATILITY DIFFERENTIAL AND DOES NOT FORM AN AZEOTROPE | CELANESE CORPORATION (US) | 1984-09-11 | — | — | US | disclosed |
| US-4470881-A | USING A HIGHER BOILING SOLVENT WHICH AFFECTS VOLATILITY DIFFERENTIAL AND DOES NOT FORM AN AZEOTROPE | CELANESE CORPORATION (US) | 1984-09-11 | — | — | US | disclosed |
| US-4138586-A | NITROALKANECARBOXYLIC ESTER WITH ALKALI HYDROXIDE, OZONIZING | HOFFMANN-LA ROCHE INC. (US) | 1979-02-06 | — | — | US | disclosed |
| US-3931322-A | FROM GAMMA-KETOESTERS AND AN ALKALI METAL ALKOXIDE | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240140888-A1 | COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER | ALKBH2, ABHD12, FAAH2 | GAA 4071/4885MGAM 2151/4885SI 3521/4885 |
| US-12281101-B2 | Bicyclic lactams and methods of use thereof | LSS, LPXN, CYP1B1 | GAA 968/4885MGAM 557/4885SI 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.